- Home
- VSCO vs TMDX Comparison
VSCO vs TMDX Comparison
Compare VSCO & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSCO
- TMDX
- Stock Information
- Founded
- VSCO 1977
- TMDX 1998
- Country
- VSCO United States
- TMDX United States
- Employees
- VSCO N/A
- TMDX N/A
- Industry
- VSCO Clothing/Shoe/Accessory Stores
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- VSCO Consumer Discretionary
- TMDX Health Care
- Exchange
- VSCO Nasdaq
- TMDX Nasdaq
- Market Cap
- VSCO 2.2B
- TMDX 2.4B
- IPO Year
- VSCO N/A
- TMDX 2019
- Fundamental
- Price
- VSCO $27.96
- TMDX $71.95
- Analyst Decision
- VSCO Hold
- TMDX Buy
- Analyst Count
- VSCO 12
- TMDX 11
- Target Price
- VSCO $40.33
- TMDX $116.10
- AVG Volume (30 Days)
- VSCO 2.0M
- TMDX 1.3M
- Earning Date
- VSCO 03-05-2025
- TMDX 02-27-2025
- Dividend Yield
- VSCO N/A
- TMDX N/A
- EPS Growth
- VSCO 54.91
- TMDX N/A
- EPS
- VSCO 1.95
- TMDX 0.94
- Revenue
- VSCO $6,207,000,000.00
- TMDX $401,090,000.00
- Revenue This Year
- VSCO $2.99
- TMDX $81.61
- Revenue Next Year
- VSCO $1.74
- TMDX $22.52
- P/E Ratio
- VSCO $14.32
- TMDX $76.78
- Revenue Growth
- VSCO 1.42
- TMDX 109.09
- 52 Week Low
- VSCO $15.12
- TMDX $55.00
- 52 Week High
- VSCO $48.73
- TMDX $177.37
- Technical
- Relative Strength Index (RSI)
- VSCO 20.67
- TMDX 52.52
- Support Level
- VSCO $31.65
- TMDX $66.81
- Resistance Level
- VSCO $33.22
- TMDX $80.00
- Average True Range (ATR)
- VSCO 1.46
- TMDX 4.14
- MACD
- VSCO -0.40
- TMDX 0.57
- Stochastic Oscillator
- VSCO 3.39
- TMDX 48.74
About VSCO Victorias Secret & Co.
Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime. The Company operates as a single segment designed to serve customers worldwide seamlessly through stores and online channels.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.